AXT Drops 16.56% with $350M Trading Volume, Placing 385th Among U.S. Stocks Despite Mixed Analyst Outlook

Market Overview

On March 6, 2026, AXT (AXTI) experienced a significant drop of 16.56%, making it one of the stock’s most turbulent sessions in recent times. Trading activity was notably high, with volume increasing by 42.38% to reach $350 million, placing it 385th among U.S. stocks by volume. Despite this steep decline, analysts remain generally positive, with an average price target of $41.14—about 6.03% above the previous closing price of $38.80. This recent setback stands in contrast to earlier momentum, such as the 12.45% surge in October 2025 after the company posted strong third-quarter results.

Factors Influencing Performance

Analyst Perspectives and Price Forecasts

Opinions among analysts covering AXTI are mixed. Approximately 77% recommend buying the stock, while 23% suggest holding. As of February 20, 2026, price targets range from $21 (B.Riley) to $29 (Craig-Hallum), indicating cautious optimism about the company’s future. However, recent downgrades—such as Needham’s move to “Hold” on January 20 and B.Riley lowering its target to $18—reflect increasing uncertainty. On average, analysts expect their price targets to be reached over a period of 474 days, implying a gradual realization of value.

Financial Results and Operational Hurdles

AXT’s fourth-quarter 2025 earnings, released on February 19, 2026, painted a mixed picture. Quarterly revenue dropped to $23 million, down from $28 million in the previous quarter and $25.1 million in the same period a year earlier. This decline was largely due to reduced sales of Indium Phosphide (InP), impacted by restrictions on Chinese export permits. Gross margins also slipped to 20.9% from 22.3%. For the full year, revenue totaled $88.3 million, representing an 11% decrease from 2024. Despite these challenges, management highlighted a $49 million order backlog and plans to double InP production, signaling both short-term obstacles and long-term opportunities in AI and optical connectivity markets.

Export Permit Issues and Competitive Standing

AXT’s reliance on Chinese export permits for InP materials remains a major challenge. InP-related revenue fell by 38% in the fourth quarter of 2025, dropping to $8 million from $13 million previously—a decline attributed to regulatory delays. B.Riley has suggested that the stock will likely trade within a range until there is more clarity on permit approvals. On the other hand, Wedbush’s increased price target of $28, based on a 30x 2027 earnings multiple, reflects confidence in AXT’s potential to benefit from the growing InP market, despite its lower margins.

Valuation Debates and Growth Expectations

Analysts are split on how to value AXT. Wedbush’s optimistic 30x multiple for 2027 earnings is higher than typical for companies with modest margins, justified by anticipated rapid growth in InP. In contrast, Riley’s more conservative outlook and $21 price target highlight concerns about execution and margin pressures. With a 40% share of the InP market and CEO Dr. Morris Young’s focus on product quality, AXT is well-positioned to benefit from rising demand driven by AI. Nevertheless, the recent 16.56% stock decline indicates that investors remain cautious about immediate challenges, including supply chain issues and broader economic uncertainty.

Strategic Direction and Future Prospects

Company leadership has projected fourth-quarter 2025 revenue between $27 million and $30 million, reflecting confidence in stabilizing demand despite ongoing export permit delays. Efforts to double InP production capacity are in line with anticipated growth in AI and optical connectivity, sectors expected to fuel long-term expansion. However, recent changes in price targets and analyst ratings suggest that investors are bracing for continued volatility. With Wedbush and Craig-Hallum maintaining “Buy” ratings and Riley taking a more cautious “Hold” stance, AXT’s future performance will likely depend on regulatory developments in China and the company’s execution of its growth plans.

Summary

The sharp decline in AXT’s share price on March 6, 2026, highlights a mix of short-term operational difficulties, regulatory uncertainty, and varied analyst opinions. While the company’s investments in InP and its substantial backlog offer reasons for optimism, achieving analyst price targets will require overcoming export permit challenges and margin pressures. Investors must weigh the company’s long-term growth potential against near-term risks, especially in an environment shaped by regulatory and economic factors.